Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001157523-05-002451
Filing Date
2005-03-11
Accepted
2005-03-11 16:12:48
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS 10-K/A d62949_10-ka.htm 10-K/A 152315
2 GRAPHIC ballot.jpg GRAPHIC 12043
3 GRAPHIC ballotx.jpg GRAPHIC 12160
4 EXHIBIT 10.52 d62949_ex10-52.htm EX-10.52 86606
5 EXHIBIT 10.53 d62949_ex10-53.htm EX-10.53 14714
6 EXHIBIT 10.54 d62949_ex10-54.htm EX-10.54 1581
7 EXHIBIT 31.1 d62949_ex31-1.htm EX-31.1 2693
8 EXHIBIT 31.2 d62949_ex31-2.htm EX-31.2 2660
  Complete submission text file 0001157523-05-002451.txt   287116
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

EIN.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21696 | Film No.: 05675717
SIC: 2836 Biological Products, (No Diagnostic Substances)